Ashley N. Lewis PharmD, BCPS

Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.

This human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate is approved for the treatment of patients with HER2-positive, metastatic breast cancer.

Tecfidera (dimethyl fumarate) has been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.

This monoclonal antibody is approved to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.

The carboxypeptidase is used to treat toxic plasma methotrexate concentrations in adult and pediatric patients.

FDA approved for the treatment of community-acquired pneumonia, ceftaroline is the first 5th-generation cephalosporin.